NMIBC
Clinical trials for NMIBC explained in plain language.
Never miss a new study
Get alerted when new NMIBC trials appear
Sign up with your email to follow new studies for NMIBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New bladder cancer combo aims to save bladders
Disease control Not yet recruitingThis early-stage trial tests a new drug called SPGL008, alone or with an existing therapy (BCG), in 120 people with high-risk bladder cancer that hasn't invaded muscle. The goal is to find a safe dose and see if it can control the cancer, potentially helping patients avoid bladde…
Matched conditions: NMIBC
Phase: PHASE1, PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated May 26, 2026 08:10 UTC
-
New drug combo aims to fight tough bladder cancer without removing bladder
Disease control Not yet recruitingThis phase 3 study tests whether a new drug (SHR-1501) given with BCG therapy works better than chemotherapy for people with a high-risk bladder cancer that has not responded to BCG alone. About 236 adults who cannot or choose not to have their bladder removed will take part. The…
Matched conditions: NMIBC
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:09 UTC
-
Promising drug combo aims to keep bladder cancer from returning
Disease control Not yet recruitingThis study tests whether adding the drug disitamab vedotin to standard BCG therapy can help keep high-risk, early-stage bladder cancer from coming back. About 182 adults whose cancer has been surgically removed will receive either the combination or BCG alone. The main goal is to…
Matched conditions: NMIBC
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated May 18, 2026 12:09 UTC